API reference
Lenvatinib mesylate
- CAS number
- 857890-39-2
- Molecular formula
- C22H23ClN4O7S
- Molecular weight
- 523 g/mol
About this molecule
Lenvatinib mesylate is a methanesulfonate salt obtained by reaction of lenvatinib with one molar equivalent of methanesulfonic acid. A multi-kinase inhibitor and orphan drug used (as its mesylate salt) for the treatment of various types of thyroid cancer that do not respond to radioiodine. It has a role as an antineoplastic agent, an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor, a fibroblast growth factor receptor antagonist, a vascular endothelial growth factor receptor antagonist and an orphan drug. It contains a lenvatinib(1+).
Source: ChEBI, via PubChem.
Identifiers
- IUPAC name
- 4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide;methanesulfonic acid
- InChIKey
- HWLFIUUAYLEFCT-UHFFFAOYSA-N
- SMILES
- COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl.CS(=O)(=O)O
- PubChem CID
- 11237762
Also known as
LENVATINIB MESYLATE · Lenvatinib mesilate · Lenvatinib methanesulfonate · lenvatinibMesylate · Lenvima · Lenvatinib (mesylate) · Lenvatinib mesilate (JAN) · Lenvatinib mesylate (USAN)
Related entries in the range
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.